Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CRN extends NAD grant for ad review

This article was originally published in The Tan Sheet

Executive Summary

The Council for Responsible Nutrition and the National Advertising Review Council extend through October 2014 their supplement advertising review program established in 2006, according to a Nov. 9 release (1"The Tan Sheet" Sept. 25, 2006). Under the extension, the recently established CRN Foundation incrementally will grant $959,000 to NARC's National Advertising Division beginning Nov. 1. "This initiative reflects one of the CRN Foundation's objectives - 'to promote truthful and non-misleading advertising of dietary supplements to consumers through programs that encourage self-regulation of advertising by industry members,'" said CRNF Executive Director Steve Mister, also the trade group's president and CEO. Mister called on dietary supplement firms to "file competitive challenges with NAD when they see dietary supplement advertisements that" disserve the industry. NAD Director Andrea Levine said, "With CRN's support, we have demonstrated that self-regulation can play an active and visible role in combating misleading and unsubstantiated dietary supplement claims, but there is still significant work left to be done.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS103497

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel